Frank Langley
Directeur Général chez TAI Diagnostics, Inc.
Profil
Frank Langley is currently the Chief Executive Officer & Director at TAI Diagnostics, Inc. and also holds the position of Director at Medical College of Wisconsin Research Foundation.
He previously worked as a Director at Prodesse, Inc. Langley received his undergraduate degree from the University of Wisconsin and his graduate degree from the University of St. Thomas.
Postes actifs de Frank Langley
Sociétés | Poste | Début |
---|---|---|
Medical College of Wisconsin Research Foundation | Directeur/Membre du Conseil | - |
TAI Diagnostics, Inc.
TAI Diagnostics, Inc. BiotechnologyHealth Technology TAI Diagnostics, Inc. provides biotechnology services. It focuses on developing innovative diagnostic tests for monitoring the health of transplanted organs. The company was founded by Aoy Tomita-Mitchell and Michael E. Mitchell in 2015 and is headquartered in Wauwatosa, WI. | Directeur Général | - |
Anciens postes connus de Frank Langley
Sociétés | Poste | Fin |
---|---|---|
Prodesse, Inc.
Prodesse, Inc. Pharmaceuticals: MajorHealth Technology Prodesse, Inc. develops, manufactures, and distributes reagents for infectious disease agents. The company's products include Pro hMPV, for detection of human metapneumovirus; ProPneumo-1 that is for detection of mycoplasma pneumoniae and chlamydophila pneumoniae; ProPertussis, for detection of bordetella pertussis; ProGastro Cd for detection of toxigenic strains of clostridium difficile and Pro hMPV+, for detection of human metapneumovirus. It was founded in 1993 and is headquartered in Waukesha, WI | Directeur/Membre du Conseil | 28/09/2010 |
Formation de Frank Langley
University of Wisconsin | Undergraduate Degree |
University of St. Thomas | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Prodesse, Inc.
Prodesse, Inc. Pharmaceuticals: MajorHealth Technology Prodesse, Inc. develops, manufactures, and distributes reagents for infectious disease agents. The company's products include Pro hMPV, for detection of human metapneumovirus; ProPneumo-1 that is for detection of mycoplasma pneumoniae and chlamydophila pneumoniae; ProPertussis, for detection of bordetella pertussis; ProGastro Cd for detection of toxigenic strains of clostridium difficile and Pro hMPV+, for detection of human metapneumovirus. It was founded in 1993 and is headquartered in Waukesha, WI | Health Technology |
Medical College of Wisconsin Research Foundation | |
TAI Diagnostics, Inc.
TAI Diagnostics, Inc. BiotechnologyHealth Technology TAI Diagnostics, Inc. provides biotechnology services. It focuses on developing innovative diagnostic tests for monitoring the health of transplanted organs. The company was founded by Aoy Tomita-Mitchell and Michael E. Mitchell in 2015 and is headquartered in Wauwatosa, WI. | Health Technology |